This company listing is no longer active
Wellbeing Digital Sciences Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Wellbeing Digital Sciences's earnings have been declining at an average annual rate of -70.7%, while the Healthcare industry saw earnings declining at 6.7% annually. Revenues have been growing at an average rate of 96.6% per year.
Belangrijke informatie
-70.7%
Groei van de winst
-54.5%
Groei van de winst per aandeel
Healthcare Groei van de industrie | -6.7% |
Inkomstengroei | 96.6% |
Rendement op eigen vermogen | n/a |
Nettomarge | -391.3% |
Laatste winstupdate | 31 Jul 2022 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Wellbeing Digital Sciences geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
31 Jul 22 | 6 | -25 | 24 | 0 |
30 Apr 22 | 6 | -48 | 26 | 0 |
31 Jan 22 | 5 | -46 | 23 | 0 |
31 Oct 21 | 3 | -41 | 18 | 0 |
31 Jul 21 | 1 | -32 | 8 | 0 |
30 Apr 21 | 0 | -4 | 3 | 0 |
31 Jan 21 | 0 | 0 | 1 | 0 |
31 Oct 20 | 0 | 1 | 1 | 0 |
31 Jul 20 | 0 | 1 | 1 | 0 |
30 Apr 20 | 0 | -2 | 0 | 0 |
31 Jan 20 | 0 | -5 | 0 | 0 |
31 Oct 19 | 0 | -5 | 0 | 0 |
31 Jul 19 | 0 | -7 | 0 | 0 |
30 Apr 19 | 0 | -4 | 0 | 0 |
31 Jan 19 | 0 | -2 | 0 | 0 |
31 Oct 18 | 0 | -2 | 0 | 0 |
31 Jul 18 | 0 | 0 | 0 | 0 |
Kwaliteitswinsten: MEDI is currently unprofitable.
Groeiende winstmarge: MEDI is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: MEDI is unprofitable, and losses have increased over the past 5 years at a rate of 70.7% per year.
Versnelling van de groei: Unable to compare MEDI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: MEDI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-38.5%).
Rendement op eigen vermogen
Hoge ROE: MEDI's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.